{
    "other_tests": [
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "Not specified",
            "findings": "Hypercellular, with 95 percent myeloperoxidase-positive blast cells. Confirmed the diagnosis of AML without maturation (FAB subtype M1).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "February 2003",
            "findings": "Hypercellular, with 30 percent myeloperoxidase-positive blast cells containing Auer rods and aberrantly expressed CD7. Increased numbers of eosinophil precursors. Diagnosed as AML, subtype M2 with eosinophilia (M2Eo).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "Not specified",
            "findings": "Normocellular but contained 35 percent myeloperoxidase-positive blast cells with Auer rods and aberrantly expressed CD7. Increased eosinophil precursors indicating AML, subtype M2Eo.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "DNA sequencing",
            "date": "Not specified",
            "findings": "212delC mutation in CEBPA gene identified in patients III-1 and III-5. Identical mutation found in germ-line DNA from buccal-swab specimens.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Mutation analysis",
            "date": "Not specified",
            "findings": "A second mutation in CEBPA was identified in Patient III-1 at the time of diagnosis. This mutation was not detectable during remission and absent in germ-line DNA.",
            "changes_over_time": "Resolved without medical intervention; normal blood counts over more than 20 months since diagnosis in both Patients III-1 and III-5."
        }
    ]
}